GVHD - 移植物抗宿主病的临床试验
总计30644个结果
-
Ann & Robert H Lurie Children's Hospital of ChicagoDana-Farber Cancer Institute; Fred Hutchinson Cancer Center; University of Minnesota完全的
-
Stanford University完全的
-
Guangdong Provincial People's HospitalSun Yat-sen University未知
-
University Health Network, TorontoHoffmann-La Roche终止
-
Andalusian Initiative for Advanced Therapies -...Andalusian Initiative for Advanced Therapies完全的
-
Janssen Pharmaceutical K.K.完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's Hospital完全的
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.完全的
-
Gilead Sciences终止
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
National Eye Institute (NEI)The Emmes Company, LLC终止
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.完全的
-
Nanfang Hospital, Southern Medical UniversityShanghai iCELL Biotechnology Co., Ltd, Shanghai, China尚未招聘急性移植物抗宿主病
-
Pharmacyclics LLC.Janssen Research & Development, LLC完全的慢性移植物抗宿主病美国, 澳大利亚, 奥地利, 加拿大, 中国, 克罗地亚, 法国, 德国, 匈牙利, 意大利, 日本, 大韩民国, 新加坡, 西班牙, 台湾
-
Gruppo Italiano Trapianto di Midollo Osseo完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Stanford University完全的
-
H. Lee Moffitt Cancer Center and Research Institute完全的